MedTrace Logo

Novel Determinants and Measures of Smokeless Tobacco Use: Study 2

NCT01067599 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 278

Last updated 2018-02-26

No results posted yet for this study

Summary

The research project will determine the level of nicotine in ST products that will lead to the greatest reduction in toxicant exposure

Conditions

  • Tobacco Use Disorder
  • Nicotine Dependence

Interventions

OTHER

Low nicotine

Comparison of different dosages of nicotine effect on tobacco use patterns, subjective response and biomarker levels.

OTHER

Medium nicotine

Comparison of different dosages of nicotine effect on tobacco use patterns, subjective response and biomarker levels.

OTHER

High nicotine

Comparison of different dosages of nicotine effect on tobacco use patterns, subjective response and biomarker levels.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Minnesota

    lead OTHER

Principal Investigators

  • Dorothy Hatsukami, PhD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2015-08-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01067599 on ClinicalTrials.gov